Eli Lilly & Co. vs. Zai Lab Limited American Depositary Shares
LLY
Eli Lilly & Co.
$1209.00 -0.92%
VS ZLABZai Lab Limited American Depositary Shares
$25.90 -0.50%
Eli Lilly & Co. and Zai Lab Limited American Depositary Shares are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| LLY | ZLAB | |
|---|---|---|
| Market Cap | $1.09 trillion | $2.86 billion |
| Revenue (TTM) | — | $449.61 million |
| Net Income (TTM) | — | $-188,213,000 |
LLY leads on 1 of 1 size & scale factors.
Valuation
| LLY | ZLAB | |
|---|---|---|
| Price / Book | — | 4.71 |
| Price / Sales | — | 6.36 |
LLY and ZLAB split the valuation factors evenly.
Profitability
| LLY | ZLAB | |
|---|---|---|
| Net Margin | — | -41.86% |
| Return on Equity | — | -31.01% |
LLY and ZLAB split the profitability factors evenly.
Risk & Sentiment
| LLY | ZLAB | |
|---|---|---|
| Short Interest | 1.29% | 1.02% |
ZLAB leads on 1 of 1 risk & sentiment factors.
Dig deeper: LLY overview, LLY financials, ZLAB overview, ZLAB financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.